Free Republic

A conventional gout medication that is utilised widely around the world has proven to be effective at combatting COVID-19, potentially adding a new weapon in defeating the virus.The discovery, achieved by a team of researchers at the University of Georgia, provides new hope of a variable therapeutic that is proficient in defeating the deadly disease that has caused over four million deaths globally. The team discovered that Probenecid – a gout medication – displayed broad antiviral properties that make it a prime candidate to fight SARS-CoV-2 infection. The gout medication may also aid in treating common and deadly respiratory viruses...

Probenecid, an FDA-approved gout treatment with “powerful antiviral properties” and minimal side effects, is “a prime candidate” for treating COVID-19 according to a new study.SciTechDaily reports on recent research from the University of Georgia, where they found that probenecid “works as a prophylactic prior to virus exposure and as a post-exposure treatment in animal models against SARS-CoV-2 and flu.”Ralph Tripp, lead author of the study, concluded, “This antiviral works for all RNA respiratory viruses we tested, including SARS-CoV-2. RSV, coronavirus and flu all circulate in the same season. Bottom line is you can potentially reduce infection and disease using this...

Published in Nature's Scientific Reports, the study found that probenecid has broad antiviral properties, making it a prime candidate to combat not only SARS-CoV-2 infection but also other common and deadly respiratory viruses like RSV and flu. Probenecid is an FDA-approved medication that's primarily used to treat gout, and it's already widely available in the U.S. The drug has been on the market for over 40 years and has minimal side effects.